Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Juvenile myelomonocytic leukemia.
Satwani P, Kahn J, Dvorak CC. Satwani P, et al. Pediatr Clin North Am. 2015 Feb;62(1):95-106. doi: 10.1016/j.pcl.2014.09.003. Pediatr Clin North Am. 2015. PMID: 25435114 Review.
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
Roman E, Cooney E, Harrison L, Militano O, Wolownik K, Hawks R, Foley S, Satwani P, Unal E, Bhatia M, Bradley B, Del Toro G, George D, Garvin J, van de Ven C, Cairo MS. Roman E, et al. Among authors: satwani p. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7164s-7170s. doi: 10.1158/1078-0432.CCR-1004-0018. Clin Cancer Res. 2005. PMID: 16203817 Clinical Trial.
Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
Satwani P, Sather H, Ozkaynak F, Heerema NA, Schultz KR, Sanders J, Kersey J, Davenport V, Trigg M, Cairo MS. Satwani P, et al. Biol Blood Marrow Transplant. 2007 Feb;13(2):218-27. doi: 10.1016/j.bbmt.2006.09.013. Biol Blood Marrow Transplant. 2007. PMID: 17241927 Free PMC article. Clinical Trial.
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
Satwani P, Bhatia M, Garvin JH Jr, George D, Dela Cruz F, Le Gall J, Jin Z, Schwartz J, Duffy D, van de Ven C, Foley S, Hawks R, Morris E, Baxter-Lowe LA, Cairo MS. Satwani P, et al. Biol Blood Marrow Transplant. 2012 Feb;18(2):324-9. doi: 10.1016/j.bbmt.2011.11.007. Epub 2011 Nov 9. Biol Blood Marrow Transplant. 2012. PMID: 22079471 Free article. Clinical Trial.
Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease.
Bhatia M, Kolva E, Cimini L, Jin Z, Satwani P, Savone M, George D, Garvin J, Paz ML, Briamonte C, Cruz-Arrieta E, Sands S. Bhatia M, et al. Among authors: satwani p. Biol Blood Marrow Transplant. 2015 Apr;21(4):666-72. doi: 10.1016/j.bbmt.2014.12.007. Epub 2015 Jan 2. Biol Blood Marrow Transplant. 2015. PMID: 25559691 Free PMC article. Clinical Trial.
Risk Factors for Subtherapeutic Tacrolimus Levels after Conversion from Continuous Intravenous Infusion to Oral in Children after Allogeneic Hematopoietic Cell Transplantation.
Kolb M, Offer K, Jin Z, Kahn J, Bhatia M, Kung AL, Garvin JH, George D, Satwani P. Kolb M, et al. Among authors: satwani p. Biol Blood Marrow Transplant. 2016 May;22(5):957-61. doi: 10.1016/j.bbmt.2016.02.005. Epub 2016 Feb 13. Biol Blood Marrow Transplant. 2016. PMID: 26880117 Free PMC article.
120 results